The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center

Background: Although there is evidence that the CYP3A4*22 variant should be considered in tacrolimus dosing in renal transplantation, its impact beyond tacrolimus dose requirements remains controversial. Methods: In a cohort of 121 kidney transplant recipients, we analyzed the CYP3A4*1B, CYP3A4*22,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Kahaar, Emaad, Winter, Stefan, Tremmel, Roman, Schaeffeler, Elke, Olbricht, Christoph J., Wieland, Eberhard, Schwab, Matthias, Shipkova, Maria, Jaeger, Simon U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775237/
https://www.ncbi.nlm.nih.gov/pubmed/31616470
http://dx.doi.org/10.3389/fgene.2019.00871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775237/
https://www.ncbi.nlm.nih.gov/pubmed/31616470
http://dx.doi.org/10.3389/fgene.2019.00871

Ejemplares similares